Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Comabella

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Neurology|September 21, 2007
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?M Tintoré, A Rovira, J Río, et al.
Journal of Neuroimmunology|March 6, 2012
Analysis of the IL28RA locus as genetic risk factor for multiple sclerosisA Lopez de Lapuente, I Alloza, R Goertsches, et al.
Journal of Neurology|December 1, 2009
Clinical features of CIS of the brainstem/cerebellum of the kind seen in MSJaume Sastre-Garriga, M Tintoré, C Nos, et al.
Stem Cell Research|October 17, 2017
Generation of six multiple sclerosis patient-derived induced pluripotent stem cell linesL Miquel-Serra, A Duarri, Y Muñoz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?R Pelayo, X Montalban, T Minoves, et al.
Revista De Neurologia|March 10, 2011
An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosisA Horga, J Castillo, J Rio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Significant clinical worsening after natalizumab withdrawal: Predictive factorsA Vidal-Jordana, M Tintoré, C Tur, et al.
Neurology|May 4, 2012
Value of NMO-IgG determination at the time of presentation as CISC Costa, G Arrambide, M Tintore, et al.
Brain : a Journal of Neurology|September 11, 2009
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosisM Comabella, J D Lünemann, J Río, et al.
Neurology|November 25, 2010
Brainstem lesions in clinically isolated syndromesM Tintore, A Rovira, G Arrambide, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Neurology|September 21, 2007
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?M Tintoré, A Rovira, J Río, et al.
Journal of Neuroimmunology|March 6, 2012
Analysis of the IL28RA locus as genetic risk factor for multiple sclerosisA Lopez de Lapuente, I Alloza, R Goertsches, et al.
Journal of Neurology|December 1, 2009
Clinical features of CIS of the brainstem/cerebellum of the kind seen in MSJaume Sastre-Garriga, M Tintoré, C Nos, et al.
Stem Cell Research|October 17, 2017
Generation of six multiple sclerosis patient-derived induced pluripotent stem cell linesL Miquel-Serra, A Duarri, Y Muñoz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?R Pelayo, X Montalban, T Minoves, et al.
Revista De Neurologia|March 10, 2011
An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosisA Horga, J Castillo, J Rio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Significant clinical worsening after natalizumab withdrawal: Predictive factorsA Vidal-Jordana, M Tintoré, C Tur, et al.
Neurology|May 4, 2012
Value of NMO-IgG determination at the time of presentation as CISC Costa, G Arrambide, M Tintore, et al.
Brain : a Journal of Neurology|September 11, 2009
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosisM Comabella, J D Lünemann, J Río, et al.
Neurology|November 25, 2010
Brainstem lesions in clinically isolated syndromesM Tintore, A Rovira, G Arrambide, et al.
Pageof 9